EP3512529A4 - Drug delivery compositions and methods - Google Patents

Drug delivery compositions and methods Download PDF

Info

Publication number
EP3512529A4
EP3512529A4 EP16916372.2A EP16916372A EP3512529A4 EP 3512529 A4 EP3512529 A4 EP 3512529A4 EP 16916372 A EP16916372 A EP 16916372A EP 3512529 A4 EP3512529 A4 EP 3512529A4
Authority
EP
European Patent Office
Prior art keywords
methods
drug delivery
delivery compositions
compositions
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16916372.2A
Other languages
German (de)
French (fr)
Other versions
EP3512529A1 (en
Inventor
Ali Razavi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP3512529A1 publication Critical patent/EP3512529A1/en
Publication of EP3512529A4 publication Critical patent/EP3512529A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A61L2300/214—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP16916372.2A 2016-09-16 2016-09-16 Drug delivery compositions and methods Withdrawn EP3512529A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/052240 WO2018052443A1 (en) 2016-09-16 2016-09-16 Drug delivery compositions and methods

Publications (2)

Publication Number Publication Date
EP3512529A1 EP3512529A1 (en) 2019-07-24
EP3512529A4 true EP3512529A4 (en) 2020-05-06

Family

ID=61619222

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16916372.2A Withdrawn EP3512529A4 (en) 2016-09-16 2016-09-16 Drug delivery compositions and methods

Country Status (2)

Country Link
EP (1) EP3512529A4 (en)
WO (1) WO2018052443A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10765782B2 (en) 2016-05-03 2020-09-08 Medtronic, Inc. Hemostatic devices and methods of use
US10933174B2 (en) 2016-05-03 2021-03-02 Medtronic, Inc. Hemostatic devices and methods of use
US10980922B2 (en) * 2016-05-03 2021-04-20 Medtronic, Inc. Hemostatic devices and methods of use
WO2022178005A1 (en) * 2021-02-17 2022-08-25 Oxion Dental, Llc Stabilized active oxygen-generating antiseptic compositions, irrigation solutions, and articles

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725576A (en) * 1983-12-29 1988-02-16 Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing L-histidine and methods for use therefore
US20110044914A1 (en) * 2008-02-08 2011-02-24 Colgate -Palmolive Company Cleaning compositions and methods
US20110212187A1 (en) * 2008-09-17 2011-09-01 Taminco Antimicrobial composition
US20110229583A1 (en) * 2010-03-17 2011-09-22 David Van Tran Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361551B1 (en) * 1998-12-11 2002-03-26 C. R. Bard, Inc. Collagen hemostatic fibers
US20120074014A1 (en) * 2010-09-27 2012-03-29 Lutran Industries, Inc. Product typically based on salt of peroxymonosulfuric acid and suitable for medicinal usage, and associated product fabrication

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725576A (en) * 1983-12-29 1988-02-16 Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing L-histidine and methods for use therefore
US20110044914A1 (en) * 2008-02-08 2011-02-24 Colgate -Palmolive Company Cleaning compositions and methods
US20110212187A1 (en) * 2008-09-17 2011-09-01 Taminco Antimicrobial composition
US20110229583A1 (en) * 2010-03-17 2011-09-22 David Van Tran Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2018052443A1 *

Also Published As

Publication number Publication date
WO2018052443A1 (en) 2018-03-22
EP3512529A1 (en) 2019-07-24

Similar Documents

Publication Publication Date Title
EP3922279B8 (en) Drug delivery compositions and uses thereof
EP3300507A4 (en) Gene delivery methods and compositions
EP3250258A4 (en) Drug delivery methods and systems
EP3357513A4 (en) Pharmaceutical composition and application thereof
EP3265064A4 (en) Drug delivery device
EP3094343A4 (en) Rapid action insulin formulations and pharmaceutical delivery systems
EP3378482A4 (en) Antitumor drug delivery formulation
EP3233192A4 (en) Compositions and methods for targeted cytokine delivery
EP3182970A4 (en) Compositions and methods for cannabinoid coatings for use in drug delivery
EP3307265A4 (en) Pharmaceutical combination and uses thereof
ZA202001044B (en) Drug delivery composition
EP3723750A4 (en) Drugs and compositions for ocular delivery
EP3091983A4 (en) Products and pharmaceutical compositions
EP3177286A4 (en) Compositions and methods for physiological delivery using cannabidiol
EP3202759A4 (en) Alpha-aminoamide derivative compound and pharmaceutical composition comprising same
EP3110422A4 (en) Compositions and methods for the delivery of therapeutics
EP3388085A4 (en) Pharmaceutical composition and applications thereof
EP3185873A4 (en) Pharmaceutical composition and methods
EP3146962A4 (en) Allisartan isoproxil solid dispersion and pharmaceutical composition thereof
EP3145508A4 (en) Clevidipine nanoparticles and pharmaceutical compositions thereof
EP3165219A4 (en) Allisartan isoproxil solid dispersion and pharmaceutical composition comprising same
EP3720844A4 (en) Drug compositions
EP3154524A4 (en) Extended-release drug delivery compositions
EP3101020A4 (en) Deuterated quinazolinone compound and pharmaceutical composition comprising same
EP3288544A4 (en) Hypromellose-graft-chitosan and methods thereof for sustained drug delivery

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20190404

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20200402

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 33/04 20060101ALI20200328BHEP

Ipc: A61K 33/40 20060101AFI20200328BHEP

Ipc: A61L 15/46 20060101ALI20200328BHEP

Ipc: A61L 15/18 20060101ALI20200328BHEP

Ipc: A61P 17/02 20060101ALI20200328BHEP

Ipc: A61L 15/26 20060101ALI20200328BHEP

Ipc: A61L 15/32 20060101ALI20200328BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20200819